Transdermal selegiline in patients receiving electroconvulsive therapy

Pamela J. Horn, Irving Reti, Geetha Jayaram

Research output: Contribution to journalArticle


Concurrent use of monoamine oxidase inhibitors (MAOIs) during a course of electroconvulsive therapy (ECT) is controversial. Objective: In this report, the authors present outcomes of this concurrent treatment approach. Method: The authors present two cases of patients taking the newest MAOI approved for depression, namely, transdermal selegiline, while receiving ECT. Results: The authors conclude that there is no evidence of complications or adverse events associated with concurrent use of ECT and low-dose transdermally administered selegiline. Conclusion: The authors further conclude that beginning a low dose of transdermal selegiline before finishing a course of ECT is a viable option for relapse prevention in the treatment of depression.

Original languageEnglish (US)
Pages (from-to)176-178
Number of pages3
Issue number2
StatePublished - Jan 1 2010

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Applied Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Transdermal selegiline in patients receiving electroconvulsive therapy'. Together they form a unique fingerprint.

  • Cite this